These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 38025742)

  • 1. TMUB1 expression is associated with the prognosis of colon cancer and immune cell infiltration.
    Lu Y; Wang K; Peng Y; Zhang J; Ju Q; Xu Q; Ouyang M; He Z
    PeerJ; 2023; 11():e16334. PubMed ID: 38025742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [METTL27 is a prognostic biomarker of colon cancer and associated with immune invasion].
    Wang K; Zhang J; Deng M; Ju Y; Ouyang M
    Nan Fang Yi Ke Da Xue Xue Bao; 2022 Apr; 42(4):486-497. PubMed ID: 35527484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TMUB1 Correlated with Immune Infiltration Is a Prognostic Marker for Colorectal Cancer.
    Hao T; Yu H; Huang D; Liu Q
    Dis Markers; 2022; 2022():5884531. PubMed ID: 35928927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive analysis of the prognostic implication and immune infiltration of CISD2 in diffuse large B-cell lymphoma.
    Zhang C; Lin Q; Li C; Qiu Y; Chen J; Zhu X
    Front Immunol; 2023; 14():1277695. PubMed ID: 38155967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KIF2C is a prognostic biomarker associated with immune cell infiltration in breast cancer.
    Liu S; Ye Z; Xue VW; Sun Q; Li H; Lu D
    BMC Cancer; 2023 Apr; 23(1):307. PubMed ID: 37016301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel HCC Prognosis Predictor EEF1E1 Is Related to Immune Infiltration and May Be Involved in EEF1E1/ATM/p53 Signaling.
    Han R; Feng P; Pang J; Zou D; Li X; Geng C; Li L; Min J; Shi J
    Front Oncol; 2021; 11():700972. PubMed ID: 34282404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High expression of TMEM200A is associated with a poor prognosis and immune infiltration in gastric cancer.
    Deng H; Li T; Wei F; Han W; Xu X; Zhang Y
    Pathol Oncol Res; 2023; 29():1610893. PubMed ID: 36741965
    [No Abstract]   [Full Text] [Related]  

  • 8. An Intratumor Heterogeneity-Related Signature for Predicting Prognosis, Immune Landscape, and Chemotherapy Response in Colon Adenocarcinoma.
    Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Xie Y
    Front Med (Lausanne); 2022; 9():925661. PubMed ID: 35872794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
    Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
    Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High MICAL-L2 expression and its role in the prognosis of colon adenocarcinoma.
    Yang Y; Ye F; Xia T; Wang Q; Zhang Y; Du J
    BMC Cancer; 2022 May; 22(1):487. PubMed ID: 35501725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction and validation of a bladder cancer risk model based on autophagy-related genes.
    Shen C; Yan Y; Yang S; Wang Z; Wu Z; Li Z; Zhang Z; Lin Y; Li P; Hu H
    Funct Integr Genomics; 2023 Jan; 23(1):46. PubMed ID: 36689018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MCM10 as a novel prognostic biomarker and its relevance to immune infiltration in gliomas.
    Tian QS; Zhang Q; Huang W
    Technol Health Care; 2023; 31(4):1301-1317. PubMed ID: 36872806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of prognostic nomograms for early-onset colon cancer in different tumor locations: a population-based study.
    Zhu S; Tu J; Pei W; Zheng Z; Bi J; Feng Q
    BMC Gastroenterol; 2023 Oct; 23(1):362. PubMed ID: 37865754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification prognosis-associated immune genes in colon adenocarcinoma.
    Miao Y; Wang J; Ma X; Yang Y; Mi D
    Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33140821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HSPA8 Is a New Biomarker of Triple Negative Breast Cancer Related to Prognosis and Immune Infiltration.
    Ying B; Xu W; Nie Y; Li Y
    Dis Markers; 2022; 2022():8446857. PubMed ID: 36452344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive analysis of the prognosis, tumor microenvironment, and immunotherapy response of SDHs in colon adenocarcinoma.
    Nan H; Guo P; Fan J; Zeng W; Hu C; Zheng C; Pan B; Cao Y; Ge Y; Xue X; Li W; Lin K
    Front Immunol; 2023; 14():1093974. PubMed ID: 36949947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of
    Wang Y; Fang Y; Zhao F; Gu J; Lv X; Xu R; Zhang B; Fang Z; Li Y
    Front Genet; 2022; 13():810292. PubMed ID: 35368661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction of a novel choline metabolism-related signature to predict prognosis, immune landscape, and chemotherapy response in colon adenocarcinoma.
    Liu C; Liu D; Wang F; Liu Y; Xie J; Xie J; Xie Y
    Front Immunol; 2022; 13():1038927. PubMed ID: 36451813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a glycolysis- and lactate-related gene signature for predicting prognosis, immune microenvironment, and drug candidates in colon adenocarcinoma.
    Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Peng J; Xie Y
    Front Cell Dev Biol; 2022; 10():971992. PubMed ID: 36081904
    [No Abstract]   [Full Text] [Related]  

  • 20. [High expression of ANKRD6 is an indicator for poor prognosis of colon adenocarcinoma].
    Zhao H; Liu G; Li Y; Yang N; Zhao J
    Nan Fang Yi Ke Da Xue Xue Bao; 2023 Oct; 43(10):1715-1724. PubMed ID: 37933647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.